Schizophrenia Bulletin

Article	Citations
Self-stigma in Serious Mental Illness: A Systematic Review of Frequency, Correlates, and Consequences	114
Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice	97
A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors	75
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse	70
Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study	67
COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study	67
Cognitive Predictors of Social and Occupational Functioning in Early Psychosis: A Systematic Review and Meta-analysis of Cross-Sectional and Longitudinal Data	65
Brief Psychotic Disorder During the National Lockdown in Italy: An Emerging Clinical Phenomenon of the COVID-19 Pandemic	58
The Self in the Spectrum: A Meta-analysis of the Evidence Linking Basic Self-Disorders and Schizophrenia	58
Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia —Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) W	55
Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans	48
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)	48
Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia	47
Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals	46
Geolocation as a Digital Phenotyping Measure of Negative Symptoms and Functional Outcome	46
Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis	45
Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders	44
Association Between Specific Childhood Adversities and Symptom Dimensions in People With Psychosis: Systematic Review and Meta-Analysis	43
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison	43
Digital phenotyping of negative symptoms: the relationship to clinician ratings	40
Meta-Analysis of Sensorimotor Gating Deficits in Patients With Schizophrenia Evaluated by Prepulse Inhibition Test	40
COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion	39
Understanding Language Abnormalities and Associated Clinical Markers in Psychosis: The Promise of Computational Methods	39
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia	38
Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia	38

Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study	38
Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium	38
Using Natural Language Processing on Electronic Health Records to Enhance Detection and Prediction of Psychosis Risk	37
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials	37
The Self and Its Prolonged Intrinsic Neural Timescale in Schizophrenia	36
Overcoming Rest–Task Divide—Abnormal Temporospatial Dynamics and Its Cognition in Schizophrenia	36
Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study	35
Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia	34
A White Matter Connection of Schizophrenia and Alzheimer’s Disease	33
Reducing Stigma Toward Individuals With Schizophrenia Using a Brief Video: A Randomized Controlled Trial of Young Adults	33
AVATAR Therapy for Distressing Voices: A Comprehensive Account of Therapeutic Targets	32
In Vivo Amygdala Nuclei Volumes in Schizophrenia and Bipolar Disorders	31
Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis—A Longitudinal Study	31
High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments	30
Exosome Transplantation From Patients With Schizophrenia Causes Schizophrenia-Relevant Behaviors in Mice: An Integrative Multi-omics Data Analysis	30
Exploring the Relationship Between Schizophrenia and Cardiovascular Disease: A Genetic Correlation and Multivariable Mendelian Randomization Study	30
Online Social Cognition Training in Schizophrenia: A Double-Blind, Randomized, Controlled Multi-Site Clinical Trial	29
Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study	29
A Review of Multimodal Hallucinations: Categorization, Assessment, Theoretical Perspectives, and Clinical Recommendations	28
Association Between Childhood Green Space, Genetic Liability, and the Incidence of Schizophrenia	27
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis	27
Understanding Identity Changes in Psychosis: A Systematic Review and Narrative Synthesis	27
Sensory and Quasi-Sensory Experiences of the Deceased in Bereavement: An Interdisciplinary and Integrative Review	27
The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains	27
Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations	27
Disrupted Intersubject Variability Architecture in Functional Connectomes in Schizophrenia	25
Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shangha	25
Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort	25
Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study	25
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial	24
Altered Peripersonal Space and the Bodily Self in Schizophrenia: A Virtual Reality Study	24
Need for Ethnic and Population Diversity in Psychosis Research	24
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia	23
Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis	23
Graph Convolutional Networks Reveal Network-Level Functional Dysconnectivity in Schizophrenia	23
Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach	23
There Is Life After the UK Clozapine Central Non-Rechallenge Database	23
Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Out	22
Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis	22
Voice-Hearing and Personification: Characterizing Social Qualities of Auditory Verbal Hallucinations in Early Psychosis	22
Latent Clinical-Anatomical Dimensions of Schizophrenia	22
Schizophrenia Polygenic Risk and Experiences of Childhood Adversity: A Systematic Review and Meta-analysis	21
Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study	21
Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?	21
Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psyc	21
A Role for Somatostatin-Positive Interneurons in Neuro-Oscillatory and Information Processing Deficits in Schizophrenia	21
Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participa	21
Changes in Default-Mode Network Associated With Childhood Trauma in Schizophrenia	20
Neurological Soft Signs Are Associated With Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia	20
Reduced Hippocampal Volume and Its Relationship With Verbal Memory and Negative Symptoms in Treatment-Naive First-Episode Adolescent-Onset Schizophrenia	20

The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia	20
Neurological Signs at the First Psychotic Episode as Correlates of Long-Term Outcome: Results From the AESOP-10 Study	20
Environmental Risk Factors in Bipolar Disorder and Psychotic Depression: A Systematic Review and Meta-Analysis of Prospective Studies	20
A Human-Specific Schizophrenia Risk Tandem Repeat Affects Alternative Splicing of a Human-Unique Isoform AS3MTd2d3 and Mushroom Dendritic Spine Density	20
Functional Impairments and Theory of Mind Deficits in Schizophrenia: A Meta-analysis of the Associations	19
Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis	19
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?	19
Hospital Presentation for Self-Harm in Youth as a Risk Marker for Later Psychotic and Bipolar Disorders: A Cohort Study of 59 476 Finns	19
Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia	19
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials	19
Anterior vs Posterior Hippocampal Subfields in an Extended Psychosis Phenotype of Multidimensional Schizotypy in a Nonclinical Sample	19
Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes	19
A Nationwide Cohort Study of Nonrandom Mating in Schizophrenia and Bipolar Disorder	19
Dimensions of Formal Thought Disorder and Their Relation to Gray- and White Matter Brain Structure in Affective and Psychotic Disorders	18
Individual Variation in Functional Brain Network Topography is Linked to Schizophrenia Symptomatology	18
Interpersonal Coordination in Schizophrenia: A Scoping Review of the Literature	18
Personalized Estimates of Brain Structural Variability in Individuals With Early Psychosis	18
Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study	18
Remote Ecological Momentary Testing of Learning and Memory in Adults With Serious Mental Illness	18
Neurological Soft Signs Predict Auditory Verbal Hallucinations in Patients With Schizophrenia	18
Neural Correlates of Self-other Distinction in Patients with Schizophrenia Spectrum Disorders: The Roles of Agency and Hand Identity	18
Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors	18
Similarities in Cortical Transcriptome Alterations Between Schizophrenia and Bipolar Disorder Are Related to the Presence of Psychosis	18
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study	17
Predictive Performance of Exposome Score for Schizophrenia in the General Population	17
Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia	17
Lack of Support for the Genes by Early Environment Interaction Hypothesis in the Pathogenesis of Schizophrenia	17
Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area	17
Timing, Distribution, and Relationship Between Nonpsychotic and Subthreshold Psychotic Symptoms Prior to Emergence of a First Episode of Psychosis	17
Autistic Symptoms and Social Functioning in Psychosis: A Network Approach	17
Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy Controls	17
Uses and Misuses of Recorded Mental Health Lived Experience Narratives in Healthcare and Community Settings: Systematic Review	17
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse	16
Machine Learning Identifies Digital Phenotyping Measures Most Relevant to Negative Symptoms in Psychotic Disorders: Implications for Clinical Trials	16
Racial and Ethnic Biases in Computational Approaches to Psychopathology	16
Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses	16
Application of a Machine Learning Algorithm for Structural Brain Images in Chronic Schizophrenia to Earlier Clinical Stages of Psychosis and Autism Spectrum Disorder: A Multiprotocol Imaging Dataset S	16
Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: I. Clinical Outcomes	16
Sleep Disturbance in Individuals at Clinical High Risk for Psychosis	16
Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis	16
A Network of Psychopathological, Cognitive, and Motor Symptoms in Schizophrenia Spectrum Disorders	16
The Schizotypal Personality Questionnaire for Children (SPQ-C): Factor Structure, Child Abuse, and Family History of Schizotypy	16
Extracting Circadian and Sleep Parameters from Longitudinal Data in Schizophrenia for the Design of Pragmatic Light Interventions	16
The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis	15
Epigenetic Age Acceleration Was Delayed in Schizophrenia	15
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials	15
Ethnoracial Variation in Risk for Psychotic Experiences	15
Cerebello-Thalamo-Cortical Hyperconnectivity Classifies Patients and Predicts Long-Term Treatment Outcome in First-Episode Schizophrenia	15
Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum	15
Toward a Complex Network of Risks for Psychosis: Combining Trauma, Cognitive Biases, Depression, and Psychotic-like Experiences on a Large Sample of Young Adults	15
A Comparative Multimodal Meta-analysis of Anisotropy and Volume Abnormalities in White Matter in People Suffering From Bipolar Disorder or Schizophrenia	15
Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia	15
Cognitive Behavioral Therapy for Prodromal Stage of Psychosis—Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis	15
The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span	14
Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode	14
The Psychopathology and Neuroanatomical Markers of Depression in Early Psychosis	14
Neurological Soft Signs Are Associated With Altered White Matter in Patients With Schizophrenia	14
Durable Cognitive Gains and Symptom Improvement Are Observed in Individuals With Recent-Onset Schizophrenia 6 Months After a Randomized Trial of Auditory Training Completed Remotely	14
White Matter Microstructural Abnormalities in the Broca’s-Wernicke’s-Putamen “Hoffman Hallucination Circuit” and Auditory Transcallosal Fibers in First-Episode Psychosis With Auditory Hallucinations	14
Sensorimotor Neuroscience in Mental Disorders: Progress, Perspectives and Challenges	14
Reliability and Replicability of Implicit and Explicit Reinforcement Learning Paradigms in People With Psychotic Disorders	14
Natural Language Processing and Psychosis: On the Need for Comprehensive Psychometric Evaluation	14
Abnormal Function in Dentate Nuclei Precedes the Onset of Psychosis: A Resting-State fMRI Study in High-Risk Individuals	13
Mapping Retinal Abnormalities in Psychosis: Meta-analytical Evidence for Focal Peripapillary and Macular Reductions	13
Quantifying Retinal Microvascular Morphology in Schizophrenia Using Swept-Source Optical Coherence Tomography Angiography	13
Dissimilarity in Sulcal Width Patterns in the Cortex can be Used to Identify Patients With Schizophrenia With Extreme Deficits in Cognitive Performance	13
Clinical Recovery Among Individuals With a First-Episode Schizophrenia an Updated Systematic Review and Meta-Analysis	13
Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis	13
Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience	13
Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response	13
Controllability of Functional Brain Networks and Its Clinical Significance in First-Episode Schizophrenia	13
Imbalance Between Prefronto-Thalamic and Sensorimotor-Thalamic Circuitries Associated with Working Memory Deficit in Schizophrenia	13
Hallucinations in Older Adults: A Practical Review	13
Impaired Membrane Lipid Homeostasis in Schizophrenia	13
Deficits in Glutamic Acid Decarboxylase 67 Immunoreactivity, Parvalbumin Interneurons, and Perineuronal Nets in the Inferior Colliculus of Subjects With Schizophrenia	13
Exercise Intervention in Individuals at Clinical High Risk for Psychosis: Benefits to Fitness, Symptoms, Hippocampal Volumes, and Functional Connectivity	12
Theta Phase Synchrony Is Sensitive to Corollary Discharge Abnormalities in Early Illness Schizophrenia but Not in the Psychosis Risk Syndrome	12
Early NMDA Receptor Ablation in Interneurons Causes an Activity-Dependent E/I Imbalance in vivo in Prefrontal Cortex Pyramidal Neurons of a Mouse Model Useful for the Study of Schizophrenia	12
Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia	12
Agency Deficits in a Human Genetic Model of Schizophrenia: Insights From 22q11DS Patients	12

Real-Time Functional Magnetic Resonance Imaging Neurofeedback for the Relief of Distressing Auditory-Verbal Hallucinations: Methodological and Empirical Advances	12
Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder—A Retrospective Chart Review	12
Black American Maternal Prenatal Choline, Offspring Gestational Age at Birth, and Developmental Predisposition to Mental Illness	12
Exploring the Relationship Between Movement Disorders and Physical Activity in Patients With Schizophrenia: An Actigraphy Study	12
Psychotic Experiences and Schizotypy in Early Adolescence Predict Subsequent Suicidal Ideation Trajectories and Suicide Attempt Outcomes From Age 18 to 38 Years	12
Sensorimotor and Activity Psychosis-Risk (SMAP-R) Scale: An Exploration of Scale Structure With Replication and Validation	12
Abnormal Gesture Perception and Clinical High-Risk for Psychosis	12
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain	12
Kraepelin’s Final Views on Dementia Praecox	12
Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial	11
Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study	11
Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms	11
Allostatic Load Effects on Cortical and Cognitive Deficits in Essentially Normotensive, Normoweight Patients with Schizophrenia	11
Fronto-Temporal Disconnection Within the Presence Hallucination Network in Psychotic Patients With Passivity Experiences	11
Neurophysiological Correlate of Emotion Regulation by Cognitive Reappraisal and Its Association With Psychotic Symptoms in Early Psychosis	11
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients	11
Relational Memory in the Early Stage of Psychosis: A 2-Year Follow-up Study	11
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia	11
Reduced Insulin-Like Growth Factor Family Member Expression Predicts Neurogenesis Marker Expression in the Subependymal Zone in Schizophrenia and Bipolar Disorder	11
Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder	11
Prenatal Kynurenine Elevation Elicits Sex-Dependent Changes in Sleep and Arousal During Adulthood: Implications for Psychotic Disorders	11
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case–Control Study	11
Healthcare Costs, School Performance, and Health-related Quality of Life in Adolescence Following Psychotic Experiences in Preadolescence: A Longitudinal Cohort Study	11
Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis	10
Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective	10
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis	10
N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance	10
Abnormal Auditory Processing and Underlying Structural Changes in 22q11.2 Deletion Syndrome	10
Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study	10
The MIR137 VNTR rs58335419 Is Associated With Cognitive Impairment in Schizophrenia and Altered Cortical Morphology	10
A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study	10
Revisiting Schizophrenia from an Evolutionary Perspective: An Association Study of Recent Evolutionary Markers and Schizophrenia	10
Association Between Human Blood Metabolome and the Risk of Psychiatric Disorders	10
BDNF and JNK Signaling Modulate Cortical Interneuron and Perineuronal Net Development: Implications for Schizophrenia-Linked 16p11.2 Duplication Syndrome	10
Comprehensive Gene Expression Analysis Detects Global Reduction of Proteasome Subunits in Schizophrenia	10
Genetic Liability for Schizophrenia and Childhood Psychopathology in the General Population	10
Cerebellar Functional Dysconnectivity in Drug-Naïve Patients With First-Episode Schizophrenia	10
The Association Between Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High-Risk for Psychosis: The Moderating Role of Social Engagement	10
Impaired Sensorimotor Gating Using the Acoustic Prepulse Inhibition Paradigm in Individuals at a Clinical High Risk for Psychosis	10
Risk Factors for Deliberate Self-harm and Suicide Among Adolescents and Young Adults With First-Episode Psychosis	10
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants	10
Network Analysis of Symptom Comorbidity in Schizophrenia: Relationship to Illness Course and Brain White Matter Microstructure	10
Depression and Psychosis Risk Shared Vulnerability for Motor Signs Across Development, Symptom Dimensions, and Familial Risk	10